Company Overview of TMune Therapeutics, Inc.
TMune Therapeutics, Inc., a biotechnology company, develops T cell therapies for the treatment of cancer and infectious diseases. Its T cell activation technology is used for the treatment of leukemia, lymphoma, and HIV. The company also evaluates clinical development programs in various areas, such as immune restoration in chronic lymphocytic leukemia, anticancer strategy in acute lymphoblastic leukemia, acute myeloid leukemia, non-Hodgkin’s lymphoma, and antiviral therapy in HIV/AIDS. TMune Therapeutics, Inc. was founded in 2008 and is based in Greenwich, Connecticut.
537 Steamboat Road
Greenwich, CT 06830
Founded in 2008
Key Executives for TMune Therapeutics, Inc.
Similar Private Companies By Industry
|Cutanogen Corporation||United States|
|Generation Biotech, LLC||United States|
|Adenios, Inc.||United States|
|Transcription Factor Therapeutics, Inc.||United States|
|SetPoint Medical Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact TMune Therapeutics, Inc., please visit app4.websitetonight.com/projects2/2/7/1/3/1773172/Home_Page.html. Company data is provided by Capital IQ. Please use this form to report any data issues.